Correction: Preferences of patients with high-risk HR+/HER2- breast cancer for adjuvant endocrine treatment: an adaptive choice-based conjoint analysis study from Germany.

IF 3 3区 医学 Q2 ONCOLOGY Breast Cancer Research and Treatment Pub Date : 2025-03-15 DOI:10.1007/s10549-025-07677-8
Achim Wöckel, Tjoung-Won Park-Simon, Agnieszka Korfel, Kirsten Raab, Hans Tesch
{"title":"Correction: Preferences of patients with high-risk HR+/HER2- breast cancer for adjuvant endocrine treatment: an adaptive choice-based conjoint analysis study from Germany.","authors":"Achim Wöckel, Tjoung-Won Park-Simon, Agnieszka Korfel, Kirsten Raab, Hans Tesch","doi":"10.1007/s10549-025-07677-8","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9133,"journal":{"name":"Breast Cancer Research and Treatment","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Cancer Research and Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10549-025-07677-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
更正:高危 HR+/HER2- 乳腺癌患者对辅助内分泌治疗的偏好:德国基于适应性选择的联合分析研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
相关文献
PARTICIPAÇÃO DISCENTE EM PROJETOS DE EXTENSÃO, UMA COMPARAÇÃO ENTRE O CONTEXTO DE PANDEMIA E O DE PÓS-PANDEMIA
IF 0 ANAIS DO III CONGRESSO NORTE-NORDESTE DE SAÚDE PÚBLICA (ONLINE) RESUMOS SIMPLESPub Date : 1900-01-01 DOI: 10.47094/iiicnnesp.2022/61
Lucas Delfino Lampugnani, C. Winter, Murilo Robusto Baldissera, Giovanni Luis Brocco, Thiago Vallone De Arruda Oliveira, Isabela Fialho Vitti, C. L. Lopes, Ana Beatriz Souza Piña, Matheus Fontes Moreira Conceição, Murilo Henrique Da Silva Pinheiro
来源期刊
CiteScore
6.80
自引率
2.60%
发文量
342
审稿时长
1 months
期刊介绍: Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.
期刊最新文献
Effects of resistance training vs high intensity interval training on body composition, muscle strength, cardiorespiratory fitness, and quality of life in survivors of breast cancer: a randomized trial. Racial disparities in treatment and outcomes between Hispanic and non-Hispanic black women with triple-negative breast cancer. Incidence, treatment patterns, and mortality for patients with breast cancer during the first year of the COVID-19 pandemic: a population-based study. Apo10 and TKTL1 in blood macrophages as potential biomarkers for early diagnosis of operable breast cancer. Inference of genetic ancestry from a multi-gene cancer panel in Colombian women with cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1